Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
September 6, 2022
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination
Nobumasa Okumura, Sho Saito, Yuki Takamatsu, et al.
Elife
|
October 7, 2015
Cell-to-cell infection by HIV contributes over half of virus infection
Shingo Iwami, Junko S Takeuchi, Shinji Nakaoka, et al.
Scientific Reports
|
April 13, 2025
Genome-wide association study of common side effects following COVID-19 booster vaccination in a cohort of corporate employees in Japan
Yosuke Omae, Seik-Soon Khor, Mihoko Shimada, et al.
Life (Basel, Switzerland)
|
July 27, 2022
Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)
Yuriko Terayama, Noriko Tomita, Junko Terada-Hirashima, et al.
The Journal of General Virology
|
December 18, 2014
Vif determines the requirement for CBF-β in APOBEC3 degradation
Rokusuke Yoshikawa, Junko S Takeuchi, Eri Yamada, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
March 26, 2022
Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19
Yusuke Miyazato, Kei Yamamoto, Yuichiro Nakaya, et al.
Plos One
|
August 16, 2018
Detection of pathogenic bacteria in the blood from sepsis patients using 16S rRNA gene amplicon sequencing analysis
Nobuo Watanabe, Kirill Kryukov, So Nakagawa, et al.
Vaccine
|
February 20, 2022
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, et al.
Scientific Data
|
February 24, 2026
8,266 SARS-CoV-2 Genomic Assemblies from Asymptomatic Carriers in Japan
Hajime Ohyanagi, Junko S Takeuchi, Yuichi Kawanishi, et al.
Journal of Virology
|
December 8, 2017
Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model
Kei Sato, Naoko Misawa, Junko S Takeuchi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
September 6, 2022
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination
Nobumasa Okumura, Sho Saito, Yuki Takamatsu, et al.
Elife
|
October 7, 2015
Cell-to-cell infection by HIV contributes over half of virus infection
Shingo Iwami, Junko S Takeuchi, Shinji Nakaoka, et al.
Scientific Reports
|
April 13, 2025
Genome-wide association study of common side effects following COVID-19 booster vaccination in a cohort of corporate employees in Japan
Yosuke Omae, Seik-Soon Khor, Mihoko Shimada, et al.
Life (Basel, Switzerland)
|
July 27, 2022
Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)
Yuriko Terayama, Noriko Tomita, Junko Terada-Hirashima, et al.
The Journal of General Virology
|
December 18, 2014
Vif determines the requirement for CBF-β in APOBEC3 degradation
Rokusuke Yoshikawa, Junko S Takeuchi, Eri Yamada, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
March 26, 2022
Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19
Yusuke Miyazato, Kei Yamamoto, Yuichiro Nakaya, et al.
Plos One
|
August 16, 2018
Detection of pathogenic bacteria in the blood from sepsis patients using 16S rRNA gene amplicon sequencing analysis
Nobuo Watanabe, Kirill Kryukov, So Nakagawa, et al.
Vaccine
|
February 20, 2022
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, et al.
Scientific Data
|
February 24, 2026
8,266 SARS-CoV-2 Genomic Assemblies from Asymptomatic Carriers in Japan
Hajime Ohyanagi, Junko S Takeuchi, Yuichi Kawanishi, et al.
Journal of Virology
|
December 8, 2017
Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model
Kei Sato, Naoko Misawa, Junko S Takeuchi, et al.
Page
of 5